FULGENT GENETICS, INC. Operating Cash Flow
FULGENT GENETICS, INC. (FLGT) reported Operating Cash Flow of -$16.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$23.76M.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $7.10M.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$78.14M, a 412.35% decline year-over-year.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $11.11M.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$101.64M, a 582.61% decline from fiscal 2024.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $21.06M, a 22.01% decline from fiscal 2023.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was $27.00M, a 89.35% decline from fiscal 2022.
- FULGENT GENETICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $253.52M, a 52.93% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$23.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$16.66M 10-Q · filed 2026-07-30 | -$94.80M derived: sum of 3 quarters · filed 2026-07-30 | -$83.70M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $7.10M 10-Q · filed 2026-05-01 | -$71.05M derived: sum of 2 quarters · filed 2026-05-01 | -$59.94M derived: sum of 3 quarters · filed 2026-05-01 | -$90.11M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | -$78.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$67.04M derived: sum of 2 quarters · filed 2026-02-27 | -$97.21M derived: sum of 3 quarters · filed 2026-07-30 | -$101.64M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $11.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$19.06M derived: sum of 2 quarters · filed 2026-07-30 | -$23.50M 10-Q · filed 2025-11-07 | $1.52M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | -$30.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$34.60M 10-Q · filed 2026-07-30 | -$9.58M derived: sum of 3 quarters · filed 2026-07-30 | -$25.09M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$4.43M 10-Q · filed 2026-05-01 | $20.59M derived: sum of 2 quarters · filed 2026-05-01 | $5.08M derived: sum of 3 quarters · filed 2026-05-01 | $9.36M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $25.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.51M derived: sum of 2 quarters · filed 2026-02-27 | $13.79M derived: sum of 3 quarters · filed 2026-02-27 | $21.06M 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$15.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$11.22M derived: sum of 2 quarters · filed 2025-11-07 | -$3.96M 10-Q · filed 2025-11-07 | $10.97M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $11.55M 10-Q · filed 2025-08-01 | $26.48M derived: sum of 3 quarters · filed 2026-02-27 | $36.72M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $7.27M 10-Q · filed 2025-05-02 | $22.20M derived: sum of 2 quarters · filed 2026-02-27 | $32.44M derived: sum of 3 quarters · filed 2026-02-27 | $42.18M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.17M derived: sum of 2 quarters · filed 2026-02-27 | $34.91M derived: sum of 3 quarters · filed 2026-02-27 | $27.00M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $10.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $19.98M derived: sum of 2 quarters · filed 2024-11-08 | $12.07M 10-Q · filed 2024-11-08 | $45.28M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $9.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.83M 10-Q · filed 2024-08-02 | $35.04M derived: sum of 3 quarters · filed 2025-02-28 | $55.81M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | -$7.91M 10-Q · filed 2024-05-03 | $25.30M derived: sum of 2 quarters · filed 2025-02-28 | $46.08M derived: sum of 3 quarters · filed 2025-02-28 | $57.20M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $33.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $53.98M derived: sum of 2 quarters · filed 2025-02-28 | $65.11M derived: sum of 3 quarters · filed 2025-02-28 | $253.52M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $20.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $31.90M derived: sum of 2 quarters · filed 2023-11-03 | $220.31M 10-Q · filed 2023-11-03 | $297.40M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $11.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $199.54M 10-Q · filed 2023-08-04 | $276.62M derived: sum of 3 quarters · filed 2024-02-28 | $428.82M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $188.41M 10-Q · filed 2023-05-05 | $265.50M derived: sum of 2 quarters · filed 2024-02-28 | $417.70M derived: sum of 3 quarters · filed 2024-02-28 | $493.81M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $77.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $229.29M derived: sum of 2 quarters · filed 2024-02-28 | $305.40M derived: sum of 3 quarters · filed 2024-02-28 | $538.58M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $152.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $228.31M derived: sum of 2 quarters · filed 2022-11-07 | $461.49M 10-Q · filed 2022-11-07 | $595.75M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $76.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $309.29M 10-Q · filed 2022-08-04 | $443.55M derived: sum of 3 quarters · filed 2023-02-28 | $452.96M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $233.18M 10-Q · filed 2022-05-05 | $367.44M derived: sum of 2 quarters · filed 2023-02-28 | $376.85M derived: sum of 3 quarters · filed 2023-02-28 | $372.44M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $134.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $143.67M derived: sum of 2 quarters · filed 2023-02-28 | $139.26M derived: sum of 3 quarters · filed 2023-02-28 | $140.63M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $9.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $5.01M derived: sum of 2 quarters · filed 2021-11-09 | $6.37M 10-Q · filed 2021-11-09 | $6.26M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$3.04M 10-Q · filed 2021-08-10 | -$3.16M derived: sum of 3 quarters · filed 2022-02-28 | $744.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-07 | $1.25M derived: sum of 2 quarters · filed 2022-02-28 | $5.15M derived: sum of 3 quarters · filed 2022-02-28 | $5.83M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $3.79M derived: sum of 2 quarters · filed 2022-02-28 | $4.46M derived: sum of 3 quarters · filed 2022-02-28 | $5.52M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.58M derived: sum of 2 quarters · filed 2020-11-09 | $5.63M 10-Q · filed 2020-11-09 | $6.41M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $675.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.73M 10-Q · filed 2020-08-05 | $2.51M derived: sum of 3 quarters · filed 2020-08-05 | $2.40M derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $1.05M 10-Q · filed 2020-05-06 | $1.83M derived: sum of 2 quarters · filed 2020-05-06 | $1.73M derived: sum of 3 quarters · filed 2020-05-06 | $1.67M derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $673.00K derived: sum of 2 quarters · filed 2020-03-13 | $616.00K derived: sum of 3 quarters · filed 2020-03-13 | -$675.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$162.00K derived: sum of 2 quarters · filed 2019-11-08 | -$1.45M 10-Q · filed 2019-11-08 | -$2.69M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$1.35M 10-Q · filed 2019-08-12 | -$2.59M derived: sum of 3 quarters · filed 2019-08-12 | -$2.09M derived: sum of 4 quarters · filed 2019-08-12 | |
| 2018-03-31 | -$1.29M 10-Q · filed 2019-05-10 | -$2.53M derived: sum of 2 quarters · filed 2019-05-10 | -$2.03M derived: sum of 3 quarters · filed 2019-05-10 | -$1.47M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$741.00K derived: sum of 2 quarters · filed 2019-03-22 | -$177.00K derived: sum of 3 quarters · filed 2019-03-22 | $1.33M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.06M derived: sum of 2 quarters · filed 2018-11-09 | $2.57M 10-Q · filed 2018-11-09 | $3.83M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $2.07M 10-Q · filed 2018-08-13 | $3.33M derived: sum of 3 quarters · filed 2018-08-13 | $4.12M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | $1.51M 10-Q · filed 2018-05-14 | $707.00K 10-Q · filed 2017-05-09 | $2.76M derived: sum of 2 quarters · filed 2018-05-14 | $3.56M derived: sum of 3 quarters · filed 2018-05-14 | $5.04M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $2.05M derived: sum of 2 quarters · filed 2018-03-20 | $3.53M derived: sum of 3 quarters · filed 2018-03-20 | $4.41M 10-K · filed 2018-03-20 | |
| 2016-09-30 | $798.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.28M derived: sum of 2 quarters · filed 2017-11-13 | $3.15M 10-Q · filed 2017-11-13 | $2.62M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.35M 10-Q · filed 2017-08-14 | $1.82M derived: sum of 3 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $875.00K 10-Q · filed 2017-05-09 | $340.00K derived: sum of 2 quarters · filed 2017-05-09 | |||
| 2015-12-31 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$969.00K 10-K · filed 2017-03-17 | |||
| 2015-09-30 | -$434.00K 10-Q · filed 2016-11-14 | ||||
| 2014-12-31 | -$4.40M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |